$HOWL
Werewolf Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Waltham, MA
HOWL chart
What traders are saying about $HOWL
Latest postsWerewolf Therapeutics, Inc. news
- Werewolf Therapeutics, Inc. (HOWL) Seasonal returns chart
Yahoo Finance UK ·
- Form 8K Werewolf Therapeutics Inc For: 9 November By Investing.com
Investing.com Nigeria ·
- Werewolf Therapeutics Reports Positive WTX-124 and WTX-330 Clinical Data
TipRanks ·
- HOWL: Werewolf Therapeutics Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
Quantisnow ·
- Werewolf Therapeutics Reports New Clinical Results for WTX-124 and WTX-330 in Solid Tumor Trials
Kalkine Media ·
- Werewolf Therapeutics reports clinical trial data for cancer drugs
Investing.com ·
- Werewolf Therapeutics’ Clinical Data for WTX-124 and WTX-330 Presented at the Society for Immunotherapy of Cancer’s (SITC) 2026 Annual Meeting
Yahoo Finance ·
- One patient's complete cancer response has lasted about three years without more cancer therapy.
Stock Titan ·
- Werewolf Therapeutics’ Clinical Data for WTX-124 and
GlobeNewswire ·
- Werewolf Therapeutics Stock Price Forecast. Should You Buy HOWL?
StockInvest.us ·
- Werewolf Therapeutics Selected for Oral Presentation and to Present Posters at the Society for Immunotherapy of Cancer’s (SITC) 2026 Annual Meeting
Yahoo Finance ·
- Roche Gets FDA Approval for Enspryng in Thyroid Eye Disease
Yahoo Finance ·
Werewolf Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$60.8M | -$70.5M | -$37.4M | -$53.8M |
| Diluted EPS | $-1.33 | $-1.63 | $-1.05 | $-1.86 |
| Total assets (year end) | $69.4M | $126.9M | $174.8M | $160.2M |
| Cash and equivalents (year end) | $57.0M | $111.0M | $134.3M | $129.3M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Werewolf Therapeutics, Inc.
- Ticker
- HOWL (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Waltham, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1785530
Frequently asked questions
What exchange is Werewolf Therapeutics, Inc. listed on?
Werewolf Therapeutics, Inc. trades on the Nasdaq under the ticker symbol HOWL.
What industry is Werewolf Therapeutics, Inc. in?
Werewolf Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Werewolf Therapeutics, Inc. headquartered?
Werewolf Therapeutics, Inc.'s business address on file with the SEC is in Waltham, MA.
When does Werewolf Therapeutics, Inc.'s fiscal year end?
Werewolf Therapeutics, Inc.'s fiscal year ends on December 31.